AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $8.32M in the quarter ending March 31, 2026, with 96.34% growth. This brings the company's revenue in the last twelve months to $79.21M, up 242.66% year-over-year. In the year 2025, AbCellera Biologics had annual revenue of $75.13M with 160.56% growth.

• Revenue (ttm): $79.21M
• Revenue Growth: +242.66%
• P/S Ratio: 20.89
• Revenue / Employee: $140,940
• Employees: 562
• Market Cap: 1.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.13M	46.30M	160.56%
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%
Dec 31, 2019	11.61M	2.78M	31.49%
Dec 31, 2018	8.83M	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error